ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to CLL
Related studies linked through entity extraction aliases.
Multicenter, Single-Arm Exploratory Phase I Clinical Study (Assessment of Safety and Efficacy) of Fully Human BAFF-R Chimeric Antigen Receptor T-Cell Injection in Relapsed/Refractory BAFF-R-Positive B-Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL
- Status
- RECRUITING
- Phase
- NA
Study of Epcoritamab as a Consolidation Therapy in CLL/SLL
- Status
- RECRUITING
- Phase
- PHASE2
A Phase I Dose Finding Study of MB-CART2219.1
- Status
- RECRUITING
- Phase
- PHASE1
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
- Status
- RECRUITING
- Phase
- PHASE3
Real-world Study of Acalabrutinib
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in China
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in China
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
- Status
- RECRUITING
- Phase
- PHASE3
Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of the Metabolism in the Lymphatic Niche of CLL
- Status
- UNKNOWN
- Phase
- N/A
Acalabrutinib in Patients With Chronic Lymphocytic Leukemia With Direct Oral Anticoagulation (CICERO)
- Status
- COMPLETED
- Phase
- N/A
Immune Response After Pneumococcal Vaccination in Patient With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- N/A
Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL
- Status
- WITHDRAWN
- Phase
- PHASE2